within Pharmacolibrary.Drugs.ATC.L;

model L01AA01
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 1,
    Cl             = 4.2 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 750 / 1000000,
    adminCount     = 1,
    Vd             = 0.0412,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.016666666666666666,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Cyclophosphamide is an alkylating agent used primarily in the treatment of various cancers (such as lymphomas, leukemias, breast cancer, and ovarian cancer) and as an immunosuppressive agent for autoimmune disorders. It is approved and widely used in clinical practice today.</p><h4>Pharmacokinetics</h4><p>Population pharmacokinetics of cyclophosphamide in adult cancer patients (both male and female, age range 20-75 years) following intravenous administration.</p><h4>References</h4><ol><li><p>Stroda, KA, et al., &amp; Lana, SE (2017). Pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide in cats after oral, intravenous, and intraperitoneal administration of cyclophosphamide. <i>American journal of veterinary research</i> 78(7) 862–866. DOI:<a href=&quot;https://doi.org/10.2460/ajvr.78.7.862&quot;>10.2460/ajvr.78.7.862</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/28650232/&quot;>https://pubmed.ncbi.nlm.nih.gov/28650232</a></p></li><li><p>Kikuchi, T, et al., &amp; Okamoto, S (2021). Pharmacokinetics of intravenous busulfan as condition for hematopoietic stem cell transplantation: comparison between combinations with cyclophosphamide and fludarabine. <i>International journal of hematology</i> 113(1) 128–133. DOI:<a href=&quot;https://doi.org/10.1007/s12185-020-02990-y&quot;>10.1007/s12185-020-02990-y</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/32886279/&quot;>https://pubmed.ncbi.nlm.nih.gov/32886279</a></p></li><li><p>Warry, E, et al., &amp; Lana, SE (2011). Pharmacokinetics of cyclophosphamide after oral and intravenous administration to dogs with lymphoma. <i>Journal of veterinary internal medicine</i> 25(4) 903–908. DOI:<a href=&quot;https://doi.org/10.1111/j.1939-1676.2011.0730.x&quot;>10.1111/j.1939-1676.2011.0730.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/21564295/&quot;>https://pubmed.ncbi.nlm.nih.gov/21564295</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end L01AA01;
